Evidence map›Paper›PMID 24398675›Full record

ArticleThe Journal of biological chemistry2014

Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver.

Rafaela Ruiz, Victoria Jideonwo, Miwon Ahn, Sneha Surendran, Vincent S Tagliabracci, Yongyong Hou, Aisha Gamble, Janos Kerner, José M Irimia-Dominguez, Michelle A Puchowicz and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Palmitate-induced downregulation of lipocalin prostaglandin DMolecular and cellular endocrinology · 2025
    Article
  12. Article
  13. The Ovary-Liver Axis: Molecular Science and Epidemiology.International journal of molecular sciences · 2025
    Review
  14. Review
  15. Inhibition of SREBP-1c rescues hepatic CYP7B1 expression and bile acid synthesis in malnourished mice.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. The Role of microRNA-22 in Metabolism.International journal of molecular sciences · 2025
    Review
  20. In defence of ferroptosis.Signal transduction and targeted therapy · 2025
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Rafaela RuizFrom the Departments of Medical and Molecular Genetics and.
Victoria Jideonwo
Miwon Ahn
Sneha Surendran
Vincent S Tagliabracci
Yongyong Hou
Aisha Gamble
Janos Kerner
José M Irimia-Dominguez
Michelle A Puchowicz
Anna DePaoli-Roach
Charles Hoppel
Peter Roach
Núria Morral
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineCase Western Reserve University · USPurdue University West Lafayette · USUniversity School · US

Funding

Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
HORMONAL CONTROL OF GLYCOGEN METABOLISMR37DK027221 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ROACH, PETER J · 1992 to 2014
$5.2M
Glycogen Metabolism and Lafora DiseaseR01NS056454 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI ROACH, PETER J · 2009 to 2018
$3.4M
Mouse Metabolic Phenotyping CenterU24DK076174 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUNENGRABER, HENRI · 2011 to 2015
$2.7M
Hepatic expression of small hairpin RNA using gutless adenoviral vectorsR01DK078595 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MORRAL, NURIA · 2008 to 2012
$1.6M
NIDDK NIH HHS DK59637NIDDK NIH HHS R01 DK078595NIDDK NIH HHS R01DK078595NIDDK NIH HHS R01DK078595-05S1NIDDK NIH HHS R37 DK027221NIDDK NIH HHS T32 DK064466NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U24 DK076174NIDDK NIH HHS U24-DK76174NINDS NIH HHS R01 NS056454
6 · The paper itself

Abstract

Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor that regulates genes in the de novo lipogenesis and glycolysis pathways. The levels of SREBP-1 are significantly elevated in obese patients and in animal models of obesity and type 2 diabetes, and a vast number of studies have implicated this transcription factor as a contributor to hepatic lipid accumulation and insulin resistance. However, its role in regulating carbohydrate metabolism is poorly understood. Here we have addressed whether SREBP-1 is needed for regulating glucose homeostasis. Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in normal and obese mice. In normal animals, SREBP-1 deficiency increased Pck1 and reduced glycogen deposition during fed conditions, providing evidence that SREBP-1 is necessary to regulate carbohydrate metabolism during the fed state. Knocking SREBP-1 down in db/db mice resulted in a significant reduction in triglyceride accumulation, as anticipated. However, mice remained hyperglycemic, which was associated with up-regulation of gluconeogenesis gene expression as well as decreased glycolysis and glycogen synthesis gene expression. Furthermore, glycogen synthase activity and glycogen accumulation were significantly reduced. In conclusion, silencing both isoforms of SREBP-1 leads to significant changes in carbohydrate metabolism and does not improve insulin resistance despite reducing steatosis in an animal model of obesity and type 2 diabetes.

Indexed as

AnimalsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Gene Expression RegulationGene Knockdown TechniquesGluconeogenesisGlycogenLiverMaleMiceObesitySterol Regulatory Element Binding Protein 1GlycogenSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1Gene ExpressionGluconeogenesisGlucose MetabolismInsulin ResistanceLiver Metabolism

Identifiers

PMID24398675
PMCPMC3937627
OpenAlexW2088522484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.